NFKB1 and rheumatoid arthritis: MiR-124a inhibits FLS proliferation and inflammation in RA by targeting the PIK3/NF-κB pathway, reducing cytokine levels, and promoting FLS apoptosis, making it a potential therapeutic target (88).